CBIO vs XLU
Crescent Biopharma, Inc. (CBIO) versus XLU (XLU) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
XLU (XLU) common stock.
Latest reported CBIO revenue for 2026-06-30 was $0. Net income was -$24.8M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
XLU does not have a complete income-statement cache yet.
CBIO currently screens at market cap $491.3M. XLU currently screens at market cap $0.
Not investment advice. Open the CBIO and XLU stock pages for the full models.
Not investment advice.